EDO-S101

≥98%

Product Code: 56809

CAS: 1236199-60-2

Molecular Weight:	Molecular Formula:	C₁₉H₂₈Cl₂N₄O₂
EC Number:	MDL Number:
Melting Point:	Boiling Point:
Density:	Storage Condition:	2-8℃

Product Description: EDO-S101 is primarily investigated for its potential in cancer treatment, particularly in hematologic malignancies. It functions as a dual inhibitor, targeting both histone deacetylases (HDACs) and DNA alkylation, which can disrupt cancer cell growth and induce apoptosis. Clinical trials have explored its efficacy in treating relapsed or refractory multiple myeloma and other cancers, showing promise in enhancing therapeutic outcomes. Its unique mechanism of action makes it a candidate for combination therapies, potentially improving the effectiveness of existing treatments. Research continues to evaluate its safety, tolerability, and broader applications in oncology.

Sizes / Availability / Pricing:

Size (g)	Availability	Price	Quantity
0.001	10-20 days	Ft69,040.48	+ -
0.005	10-20 days	Ft219,630.19	+ -

EDO-S101

EDO-S101 is primarily investigated for its potential in cancer treatment, particularly in hematologic malignancies. It functions as a dual inhibitor, targeting both histone deacetylases (HDACs) and DNA alkylation, which can disrupt cancer cell growth and induce apoptosis. Clinical trials have explored its efficacy in treating relapsed or refractory multiple myeloma and other cancers, showing promise in enhancing therapeutic outcomes. Its unique mechanism of action makes it a candidate for combination therapies, potentially improving the effectiveness of existing treatments. Research continues to evaluate its safety, tolerability, and broader applications in oncology.

Mechanism	-
Appearance	-
Longevity	-
Strength	-
Storage	-
Shelf Life	-
Allergen(s)	-
Dosage (Range)	-
Recommended Dosage	-
Dosage (Per Day)	-
Recommended Dosage (Per Day)	-
Mix Method	-
Heat Resistance	-
Stable in pH range	-
Solubility	-
Product Types	-
INCI	-

EDO-S101

≥98%

Cart